Press-release for stocks for abbv

symbols : Abbv

save search

Takeda Settles Tax Dispute with Irish Revenue over Break Fee Received by Shire
Published: 2023-10-18 (Crawled : 11:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| -11.2% | O: -1.61% H: 0.14% C: -0.27%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.86% | O: 1.24% H: 0.23% C: 0.01%

Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio
Published: 2023-10-17 (Crawled : 05:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K

Manufacturing

| -25.43% | O: -0.27% H: 1.38% C: 0.83%
VTRS A | $11.25 1.17% 1.16% 4.7M

Health Technology

| 18.8% | O: -0.95% H: 1.81% C: 0.53%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -2.56% | O: 0.2% H: 0.44% C: -0.56%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.5% | O: -0.32% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -15.25% | O: -0.4% H: 0.0% C: 0.0%
PHGE | $0.2852 -3.58% 3.16% 69K

Health Technology

| -3.33% | O: 5.0% H: 3.17% C: -1.56%
america dermatitis market

Tattoo Removal Market to increase by USD 117.09 million between 2022 to 2027 | Dermatology clinics to be the major contributing segment - Technavio
Published: 2023-10-16 (Crawled : 23:00) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M

Health Technology

| 17.59% | O: -0.68% H: 5.99% C: 5.86%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.5% | O: -0.32% H: 0.0% C: 0.0%
removal market

Infinium Global Research Forecasts Robust Growth in Ophthalmic Surgical Technologies Market: Anticipates USD 2487.63 Million Value by 2030 with a Notable CAGR of 5.25%
Published: 2023-10-16 (Crawled : 10:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -5.63% | O: 0.6% H: 0.0% C: 0.0%
GKOS | $96.5 1.44% 0.0% 700K

Health Technology

| 47.13% | O: 1.13% H: 1.87% C: 1.04%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 11.78% | O: -0.64% H: 0.0% C: 0.0%
research global growth

AbbVie's SKYRIZI® (risankizumab) Versus STELARA® (ustekinumab) Head-to-Head Study in Crohn's Disease Meets All Primary and Secondary Endpoints
Published: 2023-10-15 (Crawled : 16:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| Email alert Add to watchlist
skyrizi disease study

Growing Geriatric Population Fuels Ankylosing Spondylitis Market: Management of Pain and Mobility Gains Importance in Aging Demographics
Published: 2023-10-13 (Crawled : 16:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K

Health Technology

| -26.96% | O: -1.86% H: 0.0% C: 0.0%
ALPMY | $9.47 -1.11% 520K

Manufacturing

| -29.58% | O: -2.78% H: 0.04% C: -0.57%
VTRS A | $11.25 1.17% 1.16% 4.7M

Health Technology

| 18.92% | O: -0.21% H: 0.42% C: -1.17%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -3.59% | O: -0.55% H: 0.69% C: -0.09%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -5.02% | O: 0.64% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 19.36% | O: 1.15% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.21% | O: 0.38% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 0.65% | O: -0.59% H: 0.62% C: -0.56%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| -5.65% | O: 0.93% H: 0.26% C: -1.25%
management growing

AbbVie Announces Upadacitinib (RINVOQ®) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo as Program Advances to Phase 3
Published: 2023-10-12 (Crawled : 11:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 11.48% | O: -0.65% H: 0.0% C: 0.0%
rinvoq abbvie program trial

AbbVie Presents Long-Term Data Further Supporting the Efficacy and Safety Profile of RINVOQ (upadacitinib) in Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Published: 2023-10-11 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 11.39% | O: -0.08% H: 0.0% C: 0.0%
abbvie dermatitis rinvoq

Topical Corticosteroids Market to grow by USD 1.09 billion from 2022-2027, Asia to account for 31% of market growth - Technavio
Published: 2023-10-11 (Crawled : 05:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

Health Technology

| 8.05% | O: -1.75% H: 0.0% C: 0.0%
AZNCF | News | $138.24 -4.19% 800

Health Technology

| 1.35% | O: 0.07% H: 0.0% C: -0.38%
NVSEF | $93.6375 6.88% 82K

Health Technology

| -4.77% | O: 0.03% H: 0.0% C: -0.23%
ALPMY | $9.47 -1.11% 520K

Manufacturing

| -30.98% | O: -3.81% H: 5.97% C: 2.57%
VTRS A | $11.25 1.17% 1.16% 4.7M

Health Technology

| 16.94% | O: 0.0% H: 1.3% C: 0.73%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -4.17% | O: 1.03% H: 0.03% C: -0.07%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 6.45% | O: 0.72% H: 0.24% C: -0.13%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 11.39% | O: -0.08% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -14.65% | O: 1.1% H: 0.0% C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M

Health Technology

| 0.79% | O: -0.31% H: 0.34% C: 0.31%
asia growth market

AbbVie Showcases Breadth and Depth of Research in Crohn's Disease and Ulcerative Colitis at UEG Week 2023
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 11.6% | O: 0.19% H: 0.0% C: 0.0%
disease abbvie research week

AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
Published: 2023-10-05 (Crawled : 12:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 13.59% | O: 0.98% H: 1.08% C: -0.32%
abbvie pipeline acquire

Nature Publishes Discovery and Preclinical Results for ABBV-CLS-484, a Potential First-in-Class PTPN2/N1 Inhibitor in Cancer Immunotherapy
Published: 2023-10-04 (Crawled : 15:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.58% | O: -0.89% H: 0.0% C: 0.0%
cls-484 cancer preclinical immunotherapy potential results

AbbVie to Host Third-Quarter 2023 Earnings Conference Call
Published: 2023-10-04 (Crawled : 13:00) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.58% | O: -0.89% H: 0.0% C: 0.0%
conference abbvie

Antibacterial Drugs Market to grow by USD 9.90 billion from 2022 to 2027 | Asia to account for 42% of market growth- Technavio
Published: 2023-10-04 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

Health Technology

| 15.03% | O: 1.69% H: 0.8% C: 0.8%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 13.75% | O: 17.72% H: 0.0% C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -5.13% | O: -3.27% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 10.76% | O: 0.81% H: 0.19% C: -0.28%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 12.58% | O: -0.89% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -13.13% | O: 1.07% H: 0.0% C: 0.0%
antibacterial asia market

Regenerative Medicine Market Size to Hit USD 44.63 Billion by 2024, with at a 20.16% CAGR Over the Forecast Period | Brandessence Market Research
Published: 2023-09-26 (Crawled : 08:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K

Health Technology

| 8.93% | O: -3.05% H: 1.75% C: 0.5%
SYK | $325.43 -0.62% 0.0% 1.8M

Health Technology

| 13.24% | O: -0.92% H: 0.24% C: -3.93%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -7.32% | O: -0.07% H: 0.46% C: -0.31%
BMY | $48.93 1.3% 0.0% 10M

Health Technology

| -17.29% | O: -0.49% H: 0.65% C: -0.56%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 9.02% | O: 1.16% H: 0.13% C: -0.32%
VCEL | $43.74 -0.27% -0.27% 520K

Health Technology

| 28.65% | O: 0.38% H: 1.7% C: -1.85%
BIIB | $194.39 2.03% 1.99% 1.6M

Health Technology

| -23.78% | O: -0.02% H: 1.37% C: 1.21%
research market

Implantable Medical Devices Market to grow by USD 51.1 billion from 2022-2027 | North America to account for 45% of market growth - Technavio
Published: 2023-09-26 (Crawled : 02:00) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M

Health Technology

| -0.61% | O: -1.31% H: 0.72% C: 0.04%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 9.02% | O: 1.16% H: 0.13% C: -0.32%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 9.78% | O: -0.69% H: 0.49% C: -0.84%
LIVN | $52.31 -0.85% -0.86% 430K

Health Technology

| -3.2% | O: -0.57% H: 0.41% C: -0.69%
america medical growth market

Angiography Devices Market size to grow by USD 4072.09 mn from 2023-2027 | North America to account for 37% of market growth- Technavio
Published: 2023-09-25 (Crawled : 00:00) - prnewswire.com
CAJPY | $28.42 -0.41% 29K

n/a

| 14.52% | O: -0.97% H: 0.45% C: -0.25%
TRUMF | $16.928 -17.59% 1.9K

Health Technology

| -38.51% | O: 2.43% H: 0.0% C: -0.57%
TRUMY | $16.507 0.79% 34K

Manufacturing

| -40.15% | O: -0.46% H: 0.36% C: -0.54%
MDT | $79.48 0.37% -0.29% 6.7M

Health Technology

| -0.61% | O: -1.31% H: 0.72% C: 0.04%
PHG | $19.98 0.0% 540K

Health Technology

| -2.44% | O: 0.78% H: 0.53% C: -0.68%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 9.02% | O: 1.16% H: 0.13% C: -0.32%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 9.78% | O: -0.69% H: 0.49% C: -0.84%
america market

Engineering Services Market size to grow by USD 365.9 billion from 2022 to 2027, AECOM, AKKA Technologies SE, Babcock International Group Plc, and more among key companies- Technavio
Published: 2023-09-25 (Crawled : 04:00) - prnewswire.com
BW | News | $0.9279 -4.18% 0.0% 1.1M

Electronic Technology

| -79.33% | O: -0.67% H: 2.01% C: -1.34%
ACM | $93.35 0.12% 0.0% 540K

Industrial Services

| 13.31% | O: -0.88% H: 0.94% C: 0.39%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 8.76% | O: -0.24% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 8.5% | O: -1.17% H: 0.0% C: 0.0%
services international group market

The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, and more among key companies- Technavio
Published: 2023-09-25 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

Health Technology

| 8.89% | O: -0.81% H: 1.63% C: -1.03%
NVSEF | $93.6375 6.88% 82K

Health Technology

| 12.99% | O: 3.72% H: 0.0% C: 0.0%
VTRS A | $11.25 1.17% 1.16% 4.7M

Health Technology

| 16.7% | O: -0.21% H: 1.14% C: 1.04%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| -6.7% | O: -0.31% H: 0.98% C: 0.97%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| 6.2% | O: -0.13% H: 0.91% C: 0.88%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 8.76% | O: -0.24% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 8.5% | O: -1.17% H: 0.0% C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M

Health Technology

| 0.46% | O: -0.06% H: 0.1% C: -0.25%
abbvie treatment thyroid market

The Immunohematology Market to grow by USD 1.28 billion from 2022 to 2027 | Growing demand for blood banks and their potential to increase sales to drive the growth- Technavio
Published: 2023-09-25 (Crawled : 03:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M

Health Technology

| 7.59% | O: -0.72% H: 0.0% C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M

Health Technology

| 8.76% | O: -0.24% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 8.5% | O: -1.17% H: 0.0% C: 0.0%
sales blood growing potential market

← Previous
1
2
…
5
6
7
8
9
10
11
12
13
…
51
52
Next →

symbols : Abbv

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

symbols : Abbv save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

symbols : Abbv

save search